Authorities told reporters, authorities planned second Five-Year period of significant biomedical industry to invest in new drug research and development, areas of special funds to create 400 billion, than the Eleventh Five-Year period more than doubled. Iodobenzene Support in specific areas, to support research and development of biological products has significantly increased.

Authoritative source, the upcoming bio-pharmaceutical industry second Five-Year plan focused on R & Piperazine D and industrialization of biological products in support of efforts made towards the year 2015 more than 10 proprietary pharmaceutical industry biotechnology project.

Bio-pharmaceutical industry under the second Five-Year plan, basic drug research and development, Pyridine process improvement, technology innovation, has made large-scale production of pharmaceutical enterprises break through the special fund is expected to receive support.

Specific areas of biological products including genetic engineering, cell engineering, Linear Alkylbenzene Sulfonate enzyme engineering. To achieve these objectives, China will be the introduction of biological products research and development associated with the special support policies, such as bio-medicine with the technological transformation of the traditional medicines of special, alternative to chemical drugs with the enzyme production of special and so on. Mercaptobenzothiazole
Currently China has more than 200 pharmaceutical companies in drug research and development to carry out biological products production, isothiozolinones but the bio-pharmaceutical products in the GDP accounted for only about 10%. Experts predict that as policy support to the overweight biological products Twelve Five period is expected to make significant R & D breakthroughs.